SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac Biotech Announces Update on Nasdaq Matters BEIJING, November 30, 2017 /PRNewswire/ -- Sinovac Biotech Ltd. (Nasdaq: SVA)(the “Company” or “Sinovac”), a leading provider of biopharmaceutical products in China, announced today that the Nasdaq Hearings Panel (the “Panel”) granted the Company’s ]